Rare Tumors
Scope & Guideline
Bridging gaps in the understanding of rare tumors.
Introduction
Aims and Scopes
- Clinical Characteristics and Outcomes:
The journal emphasizes the clinical presentation, characteristics, and treatment outcomes of rare tumors, providing insights that can guide clinical practice and improve patient management. - Case Reports and Literature Reviews:
A significant portion of the journal is dedicated to detailed case reports and literature reviews, which highlight unique and rare tumor presentations, diagnostic challenges, and therapeutic approaches. - Multidisciplinary Approaches to Rare Tumors:
The journal encourages discussions on multidisciplinary treatment strategies involving surgery, chemotherapy, radiation, and emerging therapies for managing rare tumors. - Emerging Therapies and Innovations:
It explores novel therapeutic options and advancements in the management of rare tumors, including the use of immunotherapies and targeted therapies. - Global Perspectives on Rare Tumors:
The journal features studies from various geographical locations, allowing for a broader understanding of rare tumors in diverse populations and healthcare settings.
Trending and Emerging
- Innovative Immunotherapies:
There is a growing emphasis on the exploration of immunotherapy as a treatment modality for various rare tumors, reflecting a broader trend in oncology towards personalized and targeted treatment options. - Psychosocial and Quality of Life Studies:
Recent papers are increasingly addressing the psychosocial aspects and quality of life of patients with rare tumors, highlighting the importance of holistic patient care beyond just clinical outcomes. - Multidisciplinary Treatment Approaches:
The trend towards collaborative, multidisciplinary treatment strategies is evident, with more studies focusing on how combined efforts from different specialties can enhance patient outcomes for rare tumors. - Genetic and Molecular Characterization:
There is an emerging focus on the genetic and molecular profiling of rare tumors, contributing to a better understanding of tumor behavior and potential targeted therapies. - Global Health Perspectives:
An increase in studies that consider global health perspectives on rare tumors, including case reports from diverse geographical regions, is evident, promoting a more inclusive understanding of these malignancies.
Declining or Waning
- General Tumor Biology Studies:
There has been a noticeable decrease in publications focusing solely on the basic biology of rare tumors, as the journal shifts towards more clinically relevant case studies and treatment outcomes. - Traditional Chemotherapy Protocols:
The frequency of papers discussing traditional chemotherapy protocols for rare tumors is declining, possibly due to the rise of targeted therapies and immunotherapies that are gaining prominence in treatment discussions. - Epidemiological Studies of Rare Tumors:
Fewer epidemiological studies are being published, suggesting a waning interest in the statistical analysis of rare tumor incidence and prevalence, which may have been overshadowed by more pressing clinical insights and therapeutic innovations.
Similar Journals
American Journal of Case Reports
Enhancing evidence-based practice with every report.The American Journal of Case Reports, published by INT SCIENTIFIC INFORMATION, INC since 2008, serves as a crucial platform in the field of Medicine, specifically focusing on clinical cases that enhance medical knowledge and expertise. With an impact factor that reflects its quality and relevance, this journal ranks in the Q3 quartile of its category and holds a notable position at Rank #259 out of 636 in the Scopus Medicine rankings, placing it within the 59th percentile among its peers. Intended for researchers, healthcare professionals, and students, the American Journal of Case Reports advocates for the sharing of distinctive case studies, thus fostering a deeper understanding of clinical practice and patient care across a spectrum of medical disciplines. As an open access journal, it ensures widespread dissemination of vital case reports, opening avenues for global collaboration and knowledge exchange, ultimately enhancing evidence-based practice in medicine.
Endocrinology Diabetes and Metabolism Case Reports
Elevating Standards in Endocrine Research and CareEndocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.
BMJ Case Reports
Uncovering Rare Medical Narratives for Enhanced CareBMJ Case Reports is a vital resource within the field of medicine, published by the esteemed BMJ PUBLISHING GROUP. With an E-ISSN of 1757-790X and a focus on disseminating high-quality case reports, this journal serves as a platform for healthcare professionals, researchers, and students to share unique clinical experiences and uncommon presentations of medical conditions. Since its inception in 2008 and continuing through 2024, it has gained recognition for contributing to the advancement of medical knowledge, currently ranking at Q4 in the Medicine (miscellaneous) category and positioned in the 54th percentile in General Medicine according to Scopus rankings. Although it is a subscription-based journal, its impact on clinical practice and education is significant, enabling practitioners to learn from diverse case studies and improving patient care outcomes. As it aims to enhance the understanding of rare and significant medical cases, BMJ Case Reports remains an essential publication for those at the forefront of medical innovation.
Leukemia Research Reports
Advancing knowledge in leukemia research.Leukemia Research Reports, published by Elsevier Advanced Technology, is a prominent open-access journal dedicated to the latest advancements in the field of hematology and oncology. Since its launch in 2012, this journal has been a vital resource for researchers, healthcare professionals, and students aiming to disseminate and access high-quality research articles focused on various aspects of leukemia and related blood disorders. With an impact factor indicative of its significance in the field, Leukemia Research Reports currently holds a Q3 quartile ranking in both Hematology and Oncology, and is included in key databases such as Scopus. The journal not only embraces a commitment to open access, ensuring that research is freely available, but also actively promotes collaborations that strive to enhance our understanding and treatment of leukemia. Based in the United Kingdom, this journal continues to play a crucial role in fostering innovation and knowledge sharing within the medical community.
Case Reports in Endocrinology
Exploring the nuances of endocrine disorders.Case Reports in Endocrinology is a pioneering open access journal published by HINDAWI LTD, dedicated to advancing the field of endocrinology through the publication of case reports that illuminate the complexities of hormone-related disorders and metabolic issues. With its ISSN 2090-6501 and E-ISSN 2090-651X, the journal has been accessible since 2011, inviting contributions from researchers, clinicians, and students worldwide. Based in the United States, Case Reports in Endocrinology aims to disseminate critical insights and unique case analyses that contribute to the broader understanding of endocrinological conditions. While currently ranked Q4 in Endocrinology, Diabetes, and Metabolism, with Scopus placing it in the 29th percentile, the journal strives to enhance its impact and visibility. By fostering an environment for knowledge sharing and collaboration in a rapidly evolving field, this journal serves as an essential resource for those looking to deepen their understanding of endocrinological complexities and improve clinical practices.
Clinical Genitourinary Cancer
Exploring breakthroughs in cancer treatment and management.Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.
International Cancer Conference Journal
Advancing the Frontiers of Cancer ResearchInternational Cancer Conference Journal, published by Springer International Publishing AG, serves as a pivotal platform for the dissemination of cutting-edge research in the field of oncology. With a commitment to advancing the understanding, prevention, and treatment of cancer, this journal offers a forum for the presentation of innovative studies, clinical trials, and comprehensive reviews that cater to the needs of researchers, healthcare professionals, and students alike. Although currently not open access, the journal is dedicated to fostering collaboration and knowledge sharing within the cancer research community. The ISSN for this journal is 2192-3183, ensuring its listing within prominent academic databases for enhanced visibility. Hailing from Switzerland, the journal aspires to impact the global dialogue on cancer through rigorous peer-reviewed articles and special conference proceedings, making it an essential resource for those dedicated to the fight against cancer.
Archive of Clinical Cases
Empowering healthcare professionals with evidence-based findings.Archive of Clinical Cases is a premier journal dedicated to the dissemination of high-quality research in the field of clinical medicine and case studies. Published by GRIGORE T POPA UNIV MEDICINE AND PHARMACY IASI, this journal aims to bridge the gap between clinical practice and research, providing a platform for healthcare professionals, researchers, and students to share their findings and insights. With an emphasis on advancing medical knowledge through case reports, the journal plays a crucial role in enhancing evidence-based practices in clinical settings. Though the journal operates under an open-access model, its commitment to rigorous peer review ensures the integrity and quality of all published work. It invites contributions that contribute to the understanding of complex clinical scenarios, making it an invaluable resource for academics and practitioners alike. For those looking to expand their knowledge and stay abreast of the latest developments in clinical case reporting, the Archive of Clinical Cases is an indispensable addition to their academic journey.
Case Reports in Gastrointestinal Medicine
Transforming gastrointestinal medicine through shared experiences.Case Reports in Gastrointestinal Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of significant findings in the field of gastrointestinal medicine. Established in 2011, this journal champions the accessibility of scholarly work, allowing researchers, professionals, and students to explore vital case studies that enhance clinical understanding and patient care across various gastrointestinal conditions. With an emphasis on innovative practices and advances in treatment, the journal serves as an invaluable resource for those committed to furthering their knowledge and improving outcomes in gastrointestinal health. By promoting the robust sharing of case reports and clinical insights, Case Reports in Gastrointestinal Medicine not only contributes to the academic community but also supports practitioners in their quest for evidence-based practice.
Case Reports in Oncology
Unlocking Insights in OncologyCase Reports in Oncology is a peer-reviewed journal published by KARGER, dedicated to the dissemination of high-quality case studies and clinical reports in the field of oncology. Since its transition to Open Access in 2008, this Swiss-based journal has aimed to broaden the accessibility of key findings to a global audience of researchers, healthcare professionals, and students. The journal is positioned in the Q3 quartile for oncology, indicating its valuable contribution to the field, while also holding a Scopus rank of 294 out of 404 in Medicine, with a percentile of 27%. However, its open access model ensures that even those outside of traditional academic institutions can engage with critical advancements and novel insights from the oncology community. With a publication span extending from 2010 to 2024, Case Reports in Oncology serves as a crucial platform for sharing unique clinical experiences and innovative treatment strategies, ultimately enriching the practice and study of oncology.